CDNA - MCAP CO - CareDx, Inc

This daily price chart for CareDx, Inc (CDNA) reflects metrics at the level of 3.28. CareDx, Inc dominates molecular graft surveillance, replacing invasive biopsies with high-precision blood tests. Its status as a diagnostic benchmark allows the business to flexibly exercise pricing power with insurers. Stable demand from loyal clinics is supported by the implementation of innovative digital services for patient monitoring.

Market capitalization is calculated as the product of the current share price and the total number of outstanding securities, reflecting the aggregate market value of the business. Daily monitoring of this metric allows for the verification of real asset value relative to revenue, which, combined with the inelastic demand for CareDx, Inc. (CDNA) molecular analysis, makes the company's market value dynamics an accurate indicator of its capital resilience.